OncoCyte Corporation
OCX
$2.84
$0.010.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.64M | 3.36M | 9.26M | 5.58M | 9.43M |
| Total Receivables | 1.61M | 209.00K | 85.00K | 161.00K | 484.00K |
| Inventory | 410.00K | 232.00K | -- | -- | -- |
| Prepaid Expenses | 821.00K | 627.00K | 595.00K | 735.00K | 643.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 279.00K | 362.00K | 32.00K | 61.00K | 139.00K |
| Total Current Assets | 11.76M | 4.79M | 9.97M | 6.54M | 10.70M |
|
|
|||||
| Total Current Assets | 11.76M | 4.79M | 9.97M | 6.54M | 10.70M |
| Net Property, Plant & Equipment | 6.32M | 6.50M | 5.94M | 5.73M | 5.44M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 14.61M | 56.53M | 56.55M | 56.57M | 56.60M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.39M | 2.40M | 2.26M | 2.14M | 2.16M |
| Total Assets | 35.08M | 70.22M | 74.72M | 70.97M | 74.89M |
|
|
|||||
| Total Accounts Payable | 2.28M | 872.00K | 1.05M | 908.00K | 953.00K |
| Total Accrued Expenses | 3.47M | 4.01M | 2.80M | 4.28M | 3.22M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.30M | 1.28M | 1.03M | 821.00K | 665.00K |
| Total Finance Division Other Current Liabilities | 228.00K | 2.93M | 2.31M | 2.31M | 2.36M |
| Total Other Current Liabilities | 228.00K | 2.93M | 2.31M | 2.31M | 2.36M |
| Total Current Liabilities | 7.28M | 9.09M | 7.20M | 8.33M | 7.19M |
|
|
|||||
| Total Current Liabilities | 7.28M | 9.09M | 7.20M | 8.33M | 7.19M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.37M | 2.71M | 2.64M | 2.51M | 2.20M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 37.71M | 48.71M | 42.18M | 43.21M | 39.90M |
| Total Liabilities | 47.36M | 60.51M | 52.02M | 54.05M | 49.30M |
|
|
|||||
| Common Stock & APIC | 338.24M | 326.68M | 326.20M | 310.55M | 310.30M |
| Retained Earnings | -350.54M | -317.03M | -303.54M | -299.01M | -289.88M |
| Treasury Stock & Other | 21.00K | 57.00K | 37.00K | 40.00K | 49.00K |
| Total Common Equity | -12.27M | 9.71M | 22.70M | 11.59M | 20.47M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | 5.33M | 5.13M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 5.33M | 5.13M |
|
|
|||||
| Total Common Equity | -12.27M | 9.71M | 22.70M | 11.59M | 20.47M |
| Total Preferred Equity | -- | -- | -- | 5.33M | 5.13M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -12.27M | 9.71M | 22.70M | 16.92M | 25.59M |
|
|
|||||